Loading...
Home2020-11-16T07:58:06+00:00

We empower your enzymes

INOFEA AG developed a patented platform technology capable to fit enzymes to industrial applications.
About enzzen® technology
INOFEA AG
Our enzymes have positively demonstrated substantial benefits to customers in
Our enzzen®-enzymes are
Our enzzen®-enzymes

Enzzen® technology platform

INOFEA developed a unique and patented technology platform called enzzen® to fit enzymes to industrial applications.

Empower your own enzymes

INOFEA works closely with its clients to provide them with a complex line of services that sustain their processes and products.

Direct sales of enzymes

INOFEA formulated several protein digestion enzymes for improved resistance to chaotropic conditions.

Enzzen® technology licensing

INOFEA`s enzzen® is embedded into a number of applications, focusing on streamlining our client’s processes.

Meet us

Event

  • The 3rd Industrial Biocatalysis Symposium on June 10th, 2021, Wädenswil, Switzerland
Press Releases

INOFEA successfully closed its Series B financing round


16/11/2020

Muttenz, Switzerland, Nov. 16, 2020: End of September 2020 INOFEA AG executed the successful closure of its recent financing round Series B. “It was amazing to see that we have been able to oversubscribe our target, both with the support of existing and also of new shareholders”, said the CEO, Dr. Anne Timm. “The entire INOFEA Team and our Board are proud of this important milestone and we thank our investors who made this happen.” INOFEA will use its investment to grow its market position, mainly in the Pharma and Food segment. The constant growth of the customer base demonstrates the value of the technology in the white biotech sector. INOFEA’s clients are particularly in favour of the technology as it supports raw material, energy and cost savings when used in continuous manufacturing processes. The unique technology makes enzymes up to 20-35 times more stable and reusable. This supports a valuable contribution to the sustainability targets of the industry. INOFEA is in the process to file new patents, has a supply agreement, multiple research agreements and a license agreement in place. Beside Biocatalysis the company focuses on the market of diagnostics (biomarkers) where the enzzen®-enzyme technology makes complicated and for the patient painful biopsies obsolete. INOFEA is expanding its team, both on the technical and commercial side and an industry-seasoned dedicated Business Development Manager has been hired. This will enable the ambitious growth aspirations of the company in the coming years. INOFEA invites companies in the industry who are actively looking for enzymatic solutions for Biocatalysis and Diagnostics to enter into partnerships for the development of robust and recyclable enzymes.

INOFEA is certified to be one of the finalists of the EIT-Food Accelerator Network 2020


30/10/2020

INOFEA is certified to be one of the finalists of EIT-Food Accelerator Network 2020, operated by MassChallenge Switzerland.

INOFEA welcomes Nilesh Shah as Business Development Manager


01/10/2020

On 1st of October, Nilesh Shah took over the responsibility as Business Development Manager at INOFEA. His main duties will be to accelerate the revenue growth of our company and thus significantly contribute to the company’s strategy to strengthen our market position in the Food and Pharma industry. Nilesh will also strengthen our marketing activities to increase the awareness of the company. Nilesh has a long success track in business development and sales- & key account management in the Pharma- and Biopharmaceutical industries. His activities comprised as well customer acquisitions, contract negotiations and project management leading to new business opportunities with additional highly profitable revenues.
Read More